Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Clinical relevance of cancer genome sequencing.

Ku CS, Cooper DN, Roukos DH.

World J Gastroenterol. 2013 Apr 7;19(13):2011-8. doi: 10.3748/wjg.v19.i13.2011.

2.

Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.

Liu X, Wang J, Chen L.

Cancer Lett. 2013 Nov 1;340(2):270-6. doi: 10.1016/j.canlet.2012.11.002. Epub 2012 Nov 12. Review.

PMID:
23153794
3.

Research and clinical applications of cancer genome sequencing.

Ku CS, Cooper DN, Ziogas DE, Halkia E, Tzaphlidou M, Roukos DH.

Curr Opin Obstet Gynecol. 2013 Feb;25(1):3-10. doi: 10.1097/GCO.0b013e32835af17c. Review.

PMID:
23108289
4.

Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.

Lelieveld SH, Spielmann M, Mundlos S, Veltman JA, Gilissen C.

Hum Mutat. 2015 Aug;36(8):815-22. doi: 10.1002/humu.22813. Epub 2015 Jun 11.

5.

Exome versus transcriptome sequencing in identifying coding region variants.

Ku CS, Wu M, Cooper DN, Naidoo N, Pawitan Y, Pang B, Iacopetta B, Soong R.

Expert Rev Mol Diagn. 2012 Apr;12(3):241-51. doi: 10.1586/erm.12.10. Review.

PMID:
22468815
6.

Cancer whole-genome sequencing: present and future.

Nakagawa H, Wardell CP, Furuta M, Taniguchi H, Fujimoto A.

Oncogene. 2015 Dec 3;34(49):5943-50. doi: 10.1038/onc.2015.90. Epub 2015 Mar 30. Review.

PMID:
25823020
7.

Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.

Hollegaard MV, Grauholm J, Nielsen R, Grove J, Mandrup S, Hougaard DM.

Mol Genet Metab. 2013 Sep-Oct;110(1-2):65-72. doi: 10.1016/j.ymgme.2013.06.004. Epub 2013 Jun 13.

PMID:
23830478
8.

Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.

Belkadi A, Bolze A, Itan Y, Cobat A, Vincent QB, Antipenko A, Shang L, Boisson B, Casanova JL, Abel L.

Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5473-8. doi: 10.1073/pnas.1418631112. Epub 2015 Mar 31.

9.

[Cancer genome analysis through next-generation sequencing].

Aburatani H.

Gan To Kagaku Ryoho. 2011 Jan;38(1):1-6. Review. Japanese.

PMID:
21368453
10.

Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A.

Int J Mol Sci. 2017 Jan 31;18(2). pii: E308. doi: 10.3390/ijms18020308. Review.

11.

Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?

Zawati MH, Parry D, Thorogood A, Nguyen MT, Boycott KM, Rosenblatt D, Knoppers BM.

J Med Genet. 2014 Jan;51(1):68-70. doi: 10.1136/jmedgenet-2013-101934. Epub 2013 Sep 27.

PMID:
24078715
12.

Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.

Ku CS, Cooper DN, Iacopetta B, Roukos DH.

Clin Genet. 2013 Jan;83(1):2-6. doi: 10.1111/cge.12028. Epub 2012 Oct 29.

PMID:
23020236
13.

Personalized genomic analyses for cancer mutation discovery and interpretation.

Jones S, Anagnostou V, Lytle K, Parpart-Li S, Nesselbush M, Riley DR, Shukla M, Chesnick B, Kadan M, Papp E, Galens KG, Murphy D, Zhang T, Kann L, Sausen M, Angiuoli SV, Diaz LA Jr, Velculescu VE.

Sci Transl Med. 2015 Apr 15;7(283):283ra53. doi: 10.1126/scitranslmed.aaa7161.

14.

Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X.

Ku CS, Cooper DN, Wu M, Roukos DH, Pawitan Y, Soong R, Iacopetta B.

Mod Pathol. 2012 Aug;25(8):1055-68. doi: 10.1038/modpathol.2012.62. Epub 2012 Apr 20. Review.

15.

Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.

Shimoda Y, Nagashima T, Urakami K, Tanabe T, Saito J, Naruoka A, Serizawa M, Mochizuki T, Ohshima K, Ohnami S, Ohnami S, Kusuhara M, Yamaguchi K.

Biomed Res. 2016;37(6):367-379. doi: 10.2220/biomedres.37.367.

16.

Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.

Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I.

J Hum Genet. 2012 Oct;57(10):621-32. doi: 10.1038/jhg.2012.91. Epub 2012 Jul 26. Review.

PMID:
22832387
17.

Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis.

Ku CS, Wu M, Cooper DN, Naidoo N, Pawitan Y, Pang B, Iacopetta B, Soong R.

Expert Rev Mol Diagn. 2012 Mar;12(2):159-73. doi: 10.1586/erm.11.95. Review.

PMID:
22369376
18.

Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.

Chou J, Ohsumi TK, Geha RS.

Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):623-8. doi: 10.1097/ACI.0b013e3283588ca6. Review.

PMID:
23095910
19.

Next-generation diagnostics: gene panel, exome, or whole genome?

Sun Y, Ruivenkamp CA, Hoffer MJ, Vrijenhoek T, Kriek M, van Asperen CJ, den Dunnen JT, Santen GW.

Hum Mutat. 2015 Jun;36(6):648-55. doi: 10.1002/humu.22783. Epub 2015 Apr 17.

PMID:
25772376
20.

Diagnostic cancer genome sequencing and the contribution of germline variants.

Kilpivaara O, Aaltonen LA.

Science. 2013 Mar 29;339(6127):1559-62. doi: 10.1126/science.1233899. Review.

PMID:
23539595

Supplemental Content

Support Center